News
The new suite extends GMP bioconjugate production for intermediates and active pharmaceutical ingredients from early clinical phase through to late clinical phases and commercial supply. Biosynth ...
© Foto: Patrick Seeger - dpaDas Antikörpermedikament Cosentyx von Novartis wird unter anderem bereits erfolgreich bei ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results